The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 7.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it none, with a mean price target of $19.
Julius Bär Gruppe AG
JBAXY · PNK · USD · Market cap $18.8B
FAIL · Does not pass the screenAt the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Julius Bär Gruppe AG holds its Markdown at $18.24. Consolidating, no directional conviction, held for 1 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 1 days |
| Price at the screen | $18.24 |
| Valuation | 13.31 trailing · 12.23 forward price to earnings |
| Values screen | FAIL |
| Beta | 0.87 |
Five Screens, Shown in Full
Does not pass. Business activity: conventional financial services
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Its core business involves an activity the values screen does not clear. | Fail |
| Debt load | 182.31% | Below 33% | Interest-bearing debt is 182.3% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 242.43% | Below 33% | Interest-bearing cash and securities are 242.4% of assets, above the one-third limit. | Fail |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. A 6.9% margin of safety to the base estimate.
Third-party analyst targets: 2 covering, consensus None. The average target sits +7% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsSwiss Wealth Manager Fails Basic Debt Test
Julius Baer looks after old money across Europe and Asia, moving client assets through a network that has operated for generations. The numbers show steady but unspectacular progress, with revenue creeping up just 2 percent and a 20 percent profit margin that delivers an 11 percent return on equity.
We pass for one clear reason. The stock fails our ethical screen on its debt ratio, and that single breach is enough. A moderate moat and an 11.7 times forward multiple do not change the call.
The low growth rate and modest analyst targets around 19 dollars already flag limited upside, yet the debt issue alone keeps us away. Analysis, not advice.
| Forward P/E | 12.2xcheap for a company growing this fast |
| Trailing P/E | 13.3xreasonably valued |
| EPS, trailing | 1.37 |
| EPS, forward | 1.49 |
| Revenue growth | +25.7%strong top-line growth |
| Profit margin | 27.0%healthy profit margins |
| Return on equity | 16.2%a solid return on shareholder capital |
| Dividend yield | 380.00% |
| Beta | 0.87steadier than the market |
| 52-week range | 13.07 - 18.93 |
| Moat | MODERATE |
| Market cap | $18.8B |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeJBAXY trades on PNK. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it buy, with a mean price target of $18.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it buy, with a mean price target of $18.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- CFOs On the Move: Week ending July 10 CFO.com · 10 Jul 2026
- Comex Gold Settles 1.79% Lower at $4070.90 The Wall Street Journal · 8 Jul 2026
- Julius Baer names Standard Chartered executive as new CFO Private Banker International · 6 Jul 2026
- Swiss voters likely to reject stricter neutrality proposal, poll shows Investing.com · 21 Jun 2026
- Is Julius Bär Gruppe (SWX:BAER) Offering Value After Recent 1 Year Share Price Gain? Simply Wall St. · 3 Jun 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $17.17 | -5.2% | · | $948 | -5.2% |
| 2 months | $15.00 | +8.5% | $0.67 | $1,129 | +12.9% |
| 3 months | $15.04 | +8.1% | $0.67 | $1,126 | +12.6% |
| 6 months | $14.18 | +14.7% | $0.67 | $1,194 | +19.4% |
| 1 year | $12.10 | +34.4% | $0.67 | $1,399 | +39.9% |
| 2 years | $10.37 | +56.9% | $1.30 | $1,694 | +69.4% |
| 3 years | $10.75 | +51.3% | $1.91 | $1,691 | +69.1% |
| 5 years | $10.49 | +55.1% | $3.04 | $1,841 | +84.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever JBAXY does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.